In today’s recent session, 158.3 million shares of the IN8bio Inc (NASDAQ:INAB) have been traded, and its beta is 0.04. Most recently the company’s share price was $0.34, and it changed around $0.07 or 26.36% from the last close, which brings the market valuation of the company to $24.74M. INAB at last check was trading at a discount to its 52-week high of $1.74, offering almost -411.76% off that amount. The share price’s 52-week low was $0.22, which indicates that the recent value has risen by an impressive 35.29% since then. We note from IN8bio Inc’s average daily trading volume that its 10-day average is 0.44 million shares, with the 3-month average coming to 675.85K.
IN8bio Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.40. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended INAB as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. IN8bio Inc is expected to report earnings per share of -0.08 for the current quarter.
IN8bio Inc (NASDAQ:INAB) trade information
Instantly INAB has been showing a green trend so far today with a performance of 26.36% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.4177 on recent trading dayincreased the stock’s daily price by 18.6%. The company’s shares are currently up 32.70% year-to-date, but still up 34.48% over the last five days. On the other hand, IN8bio Inc (NASDAQ:INAB) is 5.57% up in the 30-day period. We can see from the shorts that 1.0 million shares have been sold at a short interest cover period of 0.51 day(s).
IN8bio Inc (INAB) estimates and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -50.62%. IN8bio Inc earnings are expected to increase by 43.67% in 2025, but the outlook is positive 32.08% per year for the next five years.
INAB Dividends
IN8bio Inc’s next quarterly earnings report is expected to be released in March.
IN8bio Inc (NASDAQ:INAB)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 21.56% of IN8bio Inc shares, and 46.46% of them are in the hands of institutional investors. The stock currently has a share float of 59.23%. IN8bio Inc stock is held by 29.0 institutions, with AIGH CAPITAL MANAGEMENT LLC being the largest institutional investor. By 2024-06-30, it held 4.9157% of the shares, which is about 2.13 million shares worth $1.8 million.
VANGUARD GROUP INC, with 3.2892% or 1.42 million shares worth $1.21 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 952.49 shares worth $0.33 million, making up 1.31% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 471.41 shares worth around $0.16 million, which represents about 0.65% of the total shares outstanding.
